Sandip Hirapara – Medgenome

View Detailed Executive Profile →

Professional Overview

  • Sandip Hirapara is the Founder and Managing Director of Alexius Biosciences, a role that commenced on October 1, 2024, showcasing a commitment to advancing biotechnological solutions.
  • Prior to founding Alexius Biosciences, Sandip served as a Patient Journey Partner at Roche from June 2023 to September 2024, indicating experience in navigating patient experiences within healthcare systems.
  • From April 2022 to May 2023, Sandip held the position of Regional Manager at MEDGENOME, contributing to the company's regional growth and client engagement strategies.
  • In the capacity of Area Manager for Business Development at MEDGENOME from September 2021 to March 2022, significant efforts were made to enhance business strategies and market penetration.
  • Sandip also worked as Manager of Business Development at MEDGENOME from May 2018 to August 2021, leading initiatives to build key partnerships and drive revenue growth.
  • Earlier roles at Eurofins included Area Manager from December 2015 to March 2018 and Assistant Manager, where responsibilities involved team leadership and operational management.
  • Prior to these roles, technical expertise was demonstrated as a Technical Support Specialist at Xcelris Labs Ltd from February 2013 to November 2015, providing valuable technical services and support.
  • Overall, Sandip Hirapara’s career trajectory reflects a strong focus on business development, technical support, and patient engagement within the biotechnology and healthcare sectors, establishing a foundation for impactful contributions at Alexius Biosciences.
Professional Experience
CompanyDesignationPeriod
MEDGENOMEArea Manager-Business DevelopmentSep 2021 – Mar 2022
MEDGENOMEManager-Business DevelopmentMay 2018 – Aug 2021
RochePatient Journey PartnerJun 2023 – Sep 2024
Xcelris Labs LtdTechnical Support SpecialistFeb 2013 – Nov 2015
EurofinsArea ManagerDec 2015 – Mar 2018
EurofinsAssistant ManagerDec 2015 – Apr 2018
MEDGENOMERegional ManagerApr 2022 – May 2023
Alexius BiosciencesFounder and Managing Director at Alexius BiosciencesOct 2024 – Present

Estimated Net Worth

Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)

Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.

Executive Contact

Official Email: Via Medgenome corporate communication desk.

Personal Contact: Not publicly disclosed.

Frequently Asked Questions

What is Sandip Hirapara's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).

How can I contact them?
Through Medgenome's official communication channels.

Is this an official profile?
No — independently created using public data.

Disclaimer

This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.

Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.

Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.

Affluense AI – Smarter Insights. Stronger Relationships with Affluents.

Last Updated: December 2025 · Published by Affluense AI (affluense.ai)

View Detailed Executive Profile →